Preferred Label : mepolizumab;

UMLS semantic type : T116 - Amino Acid, Peptide, or Protein; T121 - Pharmacologic Substance; T129 - Immunologic Factor;

Is substance : O;

Details


Main resources

You can consult :


https://www.rheuma-net.ch/fr/doc/mepolizumab/viewdocument/572
2024
Switzerland
guideline
mepolizumab
mepolizumab
Mepolizumab
Background Treatment

---
https://www.has-sante.fr/jcms/p_3380395/fr/nucala-mepolizumab-asthme-severe-a-eosinophiles-pour-les-enfants-de-6-ans-et-plus-et-les-adolescents
2022
France
evaluation of the transparency committee
mepolizumab
child, nos
mepolizumab
adolescence
severe
eosinophils
Asthma
Adolescent
asthma
Adolescent
child
Nucala
asthma
Child
Child
pulmonary eosinophilia
Eosinophilia
Child
eosinophilia
adolescent
Child

---
Nous contacter.
06/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.